World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
83
Citations
21605
World Ranking
1467
National Ranking
6

Gerhard Walzl publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gerhard Walzl sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 350 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gerhard Walzl D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gerhard Walzl sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 83 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Gerhard Walzl is affiliated with Stellenbosch University in South Africa and has a prominent research profile in the field of Medicine, focusing extensively on Infectious Diseases, Epidemiology, Immunology, Surgery, and Molecular Biology. Their work centers primarily on tuberculosis and related infectious diseases, with a substantial volume of publications contributing to these areas.

The main topics covered in their research include:

  • Tuberculosis Research and Epidemiology
  • Mycobacterium research and diagnosis
  • Infectious Diseases and Tuberculosis
  • Diagnosis and treatment of tuberculosis
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Pneumonia and Respiratory Infections
  • Immune cells in cancer

Walzl has published in a variety of scientific journals, with frequent appearances in these venues:

  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Tuberculosis
  • SSRN Electronic Journal
  • Clinical Infectious Diseases

Significant recent publications by Walzl include:

  • RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response (2020) - Scientific Reports
  • Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial (2021) - The Lancet Infectious Diseases
  • S100A8/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis (2020) - Journal of Clinical Investigation
  • Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise (2024) - The Lancet Respiratory Medicine
  • Diagnostic Accuracy of the Cepheid 3-gene Host Response Fingerstick Blood Test in a Prospective, Multi-site Study: Interim Results (2021) - Clinical Infectious Diseases

Frequent coauthors collaborating with Walzl include:

  • Stephanus T. Malherbe
  • Novel N. Chegou
  • Thomas J. Scriba
  • Nelita du Plessis
  • Mark Hatherill

Their contributions mainly focus on research that advances understanding of host-pathogen interactions in tuberculosis, identification of biomarkers for disease risk and treatment response, as well as clinical trials examining tuberculosis preventive therapies.

Best Publications

  • A blood RNA signature for tuberculosis disease risk: a prospective cohort study.

    Daniel E Zak;Adam Penn-Nicholson;Thomas J Scriba;Ethan Thompson

  • Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

    Robert S Wallis;Madhukar Pai;Madhukar Pai;Dick Menzies;Dick Menzies;T Mark Doherty

  • Immunological biomarkers of tuberculosis.

    Gerhard Walzl;Katharina Ronacher;Willem Hanekom;Thomas J. Scriba

  • Distinct, Specific IL-17- and IL-22-Producing CD4+ T Cell Subsets Contribute to the Human Anti-Mycobacterial Immune Response

    Thomas J. Scriba;Barbara Kalsdorf;Deborah-Ann Abrahams;Fatima Isaacs

  • Genital Inflammation and the Risk of HIV Acquisition in Women

    Lindi Masson;Lindi Masson;Jo Ann S. Passmore;Jo Ann S. Passmore;Lenine J. Liebenberg;Lise Werner

  • Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

    Simon Tiberi;Nelita du Plessis;Gerhard Walzl;Michael J Vjecha

  • Human gene expression profiles of susceptibility and resistance in tuberculosis

    Jeroen Maertzdorf;D. Repsilber;Shreemanta K. Parida;K. Stanley

  • Tuberculosis: advances and challenges in development of new diagnostics and biomarkers

    Gerhard Walzl;Gerhard Walzl;Ruth McNerney;Nelita du Plessis;Nelita du Plessis;Matthew Bates;Matthew Bates

  • Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis

    Sara Suliman;Ethan G. Thompson;Jayne Sutherland;January Weiner rd

  • Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response.

    Jacqueline M. Cliff;Ji-Sook Lee;Nicholas Constantinou;Jang-Eun Cho

  • Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression.

    Lindi Roberts;Jo-Ann S Passmore;Carolyn Williamson;Francesca Little

  • Biomarkers of Inflammation, Immunosuppression and Stress with Active Disease Are Revealed by Metabolomic Profiling of Tuberculosis Patients

    January Weiner;Shreemanta K Parida;Jeroen Maertzdorf;Gillian F Black

  • A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes

    Roshni Roy Chowdhury;Francesco Vallania;Qianting Yang;Cesar Joel Lopez Angel

  • Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study

    Lindi Masson;Koleka Mlisana;Francesca Little;Lise Werner

  • Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: Preliminary report

    Novel N Chegou;Gillian F Black;Martin Kidd;Paul D van Helden

  • Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection.

    Graham R. Stewart;Valerie A. Snewin;Gerhard Walzl;Tracy Hussell

  • Host blood RNA signatures predict the outcome of tuberculosis treatment

    Ethan G Thompson;Ying Du;Stephanus T Malherbe;Smitha Shankar

  • An evaluation of commercial fluorescent bead-based luminex cytokine assays.

    Joel Fleury Djoba Siawaya;Teri Roberts;Chantal Babb;Gillian Black

  • Increased Frequency of Myeloid-derived Suppressor Cells during Active Tuberculosis and after Recent Mycobacterium tuberculosis Infection Suppresses T-Cell Function

    Nelita du Plessis;Laurianne Loebenberg;Magdalena Kriel;Florian von Groote-Bidlingmaier

  • Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis

    Novel N Chegou;Jan Heyckendorf;Gerhard Walzl;Christoph Lange;Christoph Lange

  • Influenza Virus Lung Infection Protects from Respiratory Syncytial Virus–Induced Immunopathology

    Gerhard Walzl;Sabrina Tafuro;Paul Moss;Peter J.M. Openshaw

  • Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[ 18 F]fluoro- D -glucose positron emission and computed tomography

    Hanif Esmail;Hanif Esmail;Hanif Esmail;Rachel P Lai;Maia Lesosky;Katalin A Wilkinson;Katalin A Wilkinson

Frequent Co-Authors

Thomas J. Scriba
Thomas J. Scriba University of Cape Town
Hazel M. Dockrell
Hazel M. Dockrell London School of Hygiene & Tropical Medicine
Stefan H. E. Kaufmann
Stefan H. E. Kaufmann Max Planck Institute for Infection Biology
Robert J. Wilkinson
Robert J. Wilkinson The Francis Crick Institute
Tom H. M. Ottenhoff
Tom H. M. Ottenhoff Leiden University Medical Center
Paul D. van Helden
Paul D. van Helden Stellenbosch University
Willem A. Hanekom
Willem A. Hanekom University College London
Laura E. Via
Laura E. Via National Institutes of Health
Gerard Tromp
Gerard Tromp Stellenbosch University
Clifton E. Barry
Clifton E. Barry National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many professionals transition into nursing by enrolling in online BSN programs for non nurses, which provide flexible pathways for individuals without prior nursing experience. These programs are designed to build critical clinical skills that complement immunological expertise.

Accelerated options like 12-month accelerated nursing programs allow for rapid entry into the nursing field. These fast-tracked curricula align well with students eager to apply immunology knowledge in clinical settings without lengthy study periods.

For those seeking foundational roles in healthcare, enrolling in the best easiest LPN programs to get into can be a practical choice. Licensed Practical Nurse (LPN) training offers hands-on patient care experience, which is valuable for immunology-related career paths.

Advancing further, many consider nurse practitioner programs with easy admission to expand their clinical authority and specialization options. These programs often have manageable admission criteria, making advanced practice roles more accessible, especially when combining nursing expertise with immunological knowledge.

Best Scientists Citing Gerhard Walzl

Trending Scientists

Recently Published Articles